Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
NCT04674735
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Cancelled by Sponsor
Conditions
Meniere Disease
Vertigo
Vertigo Vestibular
Interventions
DRUG:
APSLXR
Sponsor
Apsen Farmaceutica S.A.